Home | Breaking Out | AI powered stock trade ideas | Bullish Engulfing | Market Signals | New Green Signal Stocks | Recent Red Arrow Top Signals | Recent Green Arrow Bottom Signals | Near Term Bottom Signals | Green Stocks with Most Upside to Analyst Target Price | New Long Term Green AI Signals | Big Tech Stocks | ETF Sector SPDRs | Solar Stocks | Chip Stocks | Airline Stocks | Social Media Stocks | Oil Stocks| Discount Store Stocks | Entertainment Stocks | EV Stocks | Restaurant Stocks | Heavy Equipment Stocks | Aerospace Stocks | Home Builders | Bank Stock Signals | Cruise Ship Stock Signals | Mining Stocks | Free AI Portfolio Analyzer | How to Read and Trade AI Powered Stock Charts| Stock Charts AI top 50 Stocks

AI Options Trading Bot (BETA)
Enter Stock Symbol to View AI powered Stock Chart

StockChartsAI.com

All Chart Prices Delayed at least 15 minutes

Before accessing this site, you agree that you have read and agree to the disclaimers at the bottom of this page.


Stock Charts AI Power Rank: 9.3
Power Rank trend -> Rising

Last Price: 103.31 - Change: 7.17 - Change %: 7.4579
02/12/2025 16:26:00 EST

Gilead Sciences Inc (GILD)

Industry: Drug Manufacturers - General

Price Support Resistance

In the past 20 trading days, GILD has been trading in a range between $98.38 and $89.88 (gray range band). Red lines on the chart represent key resistance levels and Green lines represent key support levels. As the price moves above the lines you will notice they turn green and red if price moves below a line.

GILD is breaking above top of the recent 20 day range at $98.38 and appears that it could have some more upside. If it enters a yellow zone the trend may be faltering - consider exiting or taking profits. If it enters a red zone on the chart we would exit the position.

Upside / Downside Potential

Gilead Sciences Inc $GILD entered a Green zone 18 days ago on the AI powered stock chart. Wall Street analysts have an AVG target price $99.9585, a potential upside of 4.08% from the recent price of 96.04. The stock is trading 4.65% (potential upside) below its 52 week high of $100.51 and 59.43 % (potential downside) above its 52 week low of $60.24 - based on the recent price.

Company Summary

Gilead Sciences, Inc, a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis.

GILD Website

News

Gilead Ups 2025 Outlook, Eyes Lenacapavir Launch For HIV Prevention
Tuesday, Gilead Sciences Inc GILD reported fourth-quarter 2024 adjusted EPS of $1.90, beating the consensus of $1.70.
Source: Benzinga
Wed, 12 Feb 2025 15:22:27 -0500
Sentiment: Positive
Why Gilead Sciences Stock Is Jumping Today
Shares of Gilead Sciences (GILD 7.14%) were jumping 7.9% higher on Wednesday at 11:34 a.m. The solid gain came after the big biotech company announced its 2024 fourth-quarter and full-year financial results following market close on Tuesday.
Source: The Motley Fool
Wed, 12 Feb 2025 12:21:07 -0500
Sentiment: Positive
Gilead Sciences (GILD) is a Top-Ranked Value Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Source: Zacks Investment Research
Wed, 12 Feb 2025 10:46:39 -0500
Sentiment: Positive
GILD Stock Up on Q4 Earnings and Sales Beat & Upbeat '25 Guidance
Gilead Sciences' Q4 earnings and sales beat estimates on higher HIV, oncology and liver disease drug sales. The stock is trading up.
Source: Zacks Investment Research
Wed, 12 Feb 2025 09:31:10 -0500
Sentiment: Positive
Pharma Stock Surges on Beat-and-Raise
Shares of Gilead Sciences Inc (NASDAQ:GILD) are up 4% in premarket trading, after the company delivered a strong fourth-quarter earnings beat.
Source: Schaeffers Research
Wed, 12 Feb 2025 09:06:26 -0500
Sentiment: Positive
Instituions Institution %: 88.332
Last QTR Institution change: -869074

Insiders
Insiders %: 0.29
Insiders Purchases last QTR: 0
Insiders Sales last QTR: 641261
Insiders Net last QTR: -641261

Analyst Ratings
Target Price: 99.9585
Overall Rating: 4.0714
Strong Buys (5): 13
Buys (4): 4
Holds (3): 11
Sells (2): 0
Strong Sells (1): 0

Technicals
52 Week Hi: 104.7085
52 Week Low: 60.2439
Beta: 0.192
50 Day MA: 93.2248
200 Day MA: 80.7435

Earnings / Revenue Trends
Qtr Earnings Growth YOY: -0.422
Qtr Revenue Growth YOY: 0.07
Forward PE: 12.8205
Trailing PE: 251.9756

Benefits of StockChartsAI.com System:

  • Get a Daily List of Stocks Starting New Trends
  • Upload Your Stocks to Quickly See and Track Signals
  • Easy to Understand AI Stock Signals
  • Analysis of Historical Signal Trend Analysis for each stock
  • Search/View AI Stock Signals of Russel 1000 Stocks
  • Easy to Understand AI Stock Signals
  • And MUCH MUCH more!

1000

Stock Analyzed Each Night

Portfolio

Easily Upload Track Your Stocks

Trends

See Lists of Stocks Starting New Trends

The information contained on this website is solely for educational purposes, and does not constitute investment advice. The risk of trading in securities markets can be substantial. By accessing this site, you agree we are not liable, whether in contract, tort (including negligence) or otherwise, in respect of any damage, expense or other loss you may suffer arising out of such information or any reliance you may place upon such information from this site. Stocks, Futures and options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stock, futures and options markets. Don't trade with money you can't afford to lose. This website is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this website. The past performance of any trading system or methodology is not necessarily indicative of future results. Individual results may vary, and testimonials are not claimed to represent typical results. All testimonials are by real people, and may not reflect the typical purchaser’s experience, and are not intended to represent or guarantee that anyone will achieve the same or similar results. HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY, SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.